Introducing the GenapSys™ Sequencer
Sequencing without compromise
The GenapSys™ Sequencer is exceptionally accurate, incredibly scalable, and amazingly affordable.
Introducing the GenapSys™ Sequencer
Innovative electrical detection enables accurate, scalable and affordable sequencing.
GenapSys has developed a novel electrical-based platform capable of accurately detecting single base incorporations. The semiconductor chip-based detection modality allows the system to be compact, scalable, and affordable.
DISCOVER OUR TECHNOLOGY
GenapSys technology achieves
>80% of bases >Q30
The GenapSys platform has been successfully demonstrated in a range of
applications that include targeted sequencing to elucidate
both germline and somatic mutations, as well as sequencing a range of small genomes.
The latest GenapSys news & upcoming events.
Redwood City, CA (Nov. 20, 2019) -- GenapSys Inc. announced today that it has completed a $90 million funding
round, led by Foresite Capital to commercialize the smallest and most affordable highly accurate sequencer ever
developed.
Read more >
GenapSys Targeting Smaller Labs With New Low-Cost Sequencer
Read more >
Meet GenapSys at the Association of Biomolecular Resource Facilities
Read more >
